View : 17 Download: 0

Structural determinants of efficacy at A3 adenosine receptors: Modification of the ribose moiety

Title
Structural determinants of efficacy at A3 adenosine receptors: Modification of the ribose moiety
Authors
Gao Z.-G.Jeong L.S.Moon H.R.Kim H.O.Choi W.J.Shin D.H.Elhalem E.Comin M.J.Melman N.Mamedova L.Gross A.S.Rodriguez J.B.Jacobson K.A.
Ewha Authors
정낙신
Issue Date
2004
Journal Title
Biochemical Pharmacology
ISSN
0006-2952JCR Link
Citation
vol. 67, no. 5, pp. 893 - 901
Indexed
SCI; SCIE; SCOPUS WOS scopus
Abstract
We have found previously that structural features of adenosine derivatives, particularly at the N6- and 2-positions of adenine, determine the intrinsic efficacy as A3 adenosine receptor (AR) agonists. Here, we have probed this phenomenon with respect to the ribose moiety using a series of ribose-modified adenosine derivatives, examining binding affinity and activation of the human A3 AR expressed in CHO cells. Both 2′- and 3′-hydroxyl groups in the ribose moiety contribute to A3 AR binding and activation, with 2′-OH being more essential. Thus, the 2′-fluoro substitution eliminated both binding and activation, while a 3′-fluoro substitution led to only a partial reduction of potency and efficacy at the A3 AR. A 5′-uronamide group, known to restore full efficacy in other derivatives, failed to fully overcome the diminished efficacy of 3′-fluoro derivatives. The 4′-thio substitution, which generally enhanced A3 AR potency and selectivity, resulted in 5′-CH2OH analogues (10 and 12) which were partial agonists of the A3 AR. Interestingly, the shifting of the N6-(3- iodobenzyl)adenine moiety from the 1′- to 4′-position had a minor influence on A3 AR selectivity, but transformed 15 into a potent antagonist (16) (Ki=4.3nM). Compound 16 antagonized human A 3 AR agonist-induced inhibition of cyclic AMP with a KB value of 3.0nM. A novel apio analogue (20) of neplanocin A, was a full A 3 AR agonist. The affinities of selected, novel analogues at rat ARs were examined, revealing species differences. In summary, critical structural determinants for human A3 AR activation have been identified, which should prove useful for further understanding the mechanism of receptor activation and development of more potent and selective full agonists, partial agonists and antagonists for A3 ARs. © 2003 Elsevier Inc. All rights reserved.
DOI
10.1016/j.bcp.2003.10.006
Appears in Collections:
약학대학 > 약학과 > Journal papers
Files in This Item:
There are no files associated with this item.
Export
RIS (EndNote)
XLS (Excel)
XML


qrcode

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.

BROWSE